Similar Items

Cover Image

Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metformin

Objective  Recent European Guidelines for Diabetes, Prediabetes and Cardiovascular Diseases introduced a shift in managing patients with type 2 diabetes at high risk for or established cardiovascular (CV) disease by recommending GLP-1 receptor agonists and SGLT-2 inhibitors as initial glucose-lower...

Full description

Saved in:
Bibliographic Details
Institution:Universidad EIA
Main Authors: Ferrannini, Giulia, Gerstein, Hertzel, Colhoun, Helen Martina, Dagenais, Gilles R., Diaz, Rafael, Dyal, Leanne, Lakshmanan, Mark, Mellbin, Linda, Probstfield, Jeffrey, Riddle, Matthew Casey, Shaw, Jonathan Edward, Avezum, Alvaro, Basile, Jan Neil, Cushman, William C., Jansky, Petr, Keltai, Mátyás, Lanas, Fernando, Leiter, Lawrence Alan, Lopez-Jaramillo, Patricio, Pais, Prem, Pīrāgs, Valdis, Pogosova, Nana, Raubenheimer, Peter Johann, Huey-Herng Sheu, Wayne, Rydén, Lars, Masira
Format: Artículo de revista
Language:English
Published: European Society of Cardiology 2021-07-07
Subjects:
Cardiovascular disease
GLP-1-based therapy
Metformin
Mortality
Morbidity
Online Access:https://repositorio.udes.edu.co/handle/001/6070
Tags: Add Tag
No Tags, Be the first to tag this record!